RecruitingNCT06595160
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients
Sponsor
Emory University
Enrollment
87 participants
Start Date
Aug 5, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- \* Age ≥ 18 years with signed informed consent form
- Patients must have a histological diagnosis of PDAC
- Resectable or borderline resectable PDAC on imaging
Exclusion Criteria3
- \* Patients with locally advanced and metastatic stage IV PDAC
- Patients who have already received or completed neoadjuvant chemotherapy for PDAC
- Patients with active malignancy receiving systemic therapy
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06595160
Related Trials
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
NCT040056901 location
A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer
NCT071246111 location
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment
NCT065746201 location
PULSAR in Systemic Therapy for Pancreatic Cancer
NCT072696261 location
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
NCT044849091 location